Saint Louis University (SLU)

University / College


Location: St. Louis, MO, United States (USA) (US) US

ISNI: 0000000419369342

ROR: https://ror.org/01p7jjy08

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation (2019) Minutti CM, Modak R, Macdonald F, Li F, Smyth DJ, Dorward DA, Blair N, et al. Journal article De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies (2019) Platzer K, Sticht H, Edwards SL, Allen W, Angione KM, Bonati MT, Brasington C, et al. Journal article International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management (2018) Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, Bauer JM, et al. Journal article Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution Efficacy and Safety of Seladelpar, a Selective Peroxisome Proliferator-Activated Receptor Delta Agonist, in Primary Biliary Cholangitis: 52-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 Study (2018) Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, Kremer A, et al. Conference contribution Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution Orphan Nuclear Receptor Ror alpha Is a Key Regulator of Tgf beta- and WNT-Signaling in Fibrotic Diseases (2018) Kagwiria R, Liang R, Matei AE, Sihler N, Chen CW, Burris T, Distler O, et al. Conference contribution The Nuclear Receptor ROR-Alpha As a Key Checkpoint of Tissue Repair (2017) Kagwiria R, Liang R, Chen CW, Burris T, Schett G, Distler J Conference contribution Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study (2014) Conway CR, Chibnall JT, Cumming P, Mintun MA, Gebara MAI, Perantie DC, Price JL, et al. Journal article Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, et al. Journal article
1 2 3